ADVANCE Blueprint submitted to IMI

The WP7 deliverable D7.7 Blueprint of a framework to rapidly provide scientific evidence on post-marketing vaccination benefits and risks for informed decisions has been submitted to IMI. Click here to read more.

ADVANCE was presented at the Vaccine Conference 2018

On the 17th of September Professor Miriam Sturkenboom delivered the lecture titled “The ADVANCE system for monitoring benefits and risks of vaccines in EU”. Vaccine Conference is organised by Vaccine, the premier journal for those...

ADVANCE at the 2018 Big Data for Pharmacovigilance conference

The Big Data for Pharmacovigilance conference took place in London on 20-21st of June. The conference is taught by a panel of international expert speakers and for this edition the Project Coordinator Professor Miriam Sturkenboom presented the...

ADVANCE at the 2018 Mackenzie Lecture & Conference

The Mackenzie Lecture is an annual event held in honour of Sir James Mackenzie, a pioneer in research in general practice, use of medical records and the safe use of medicines. On the 9th of May Professor Miriam Sturkenboom delivered the...

ADVANCE in Horizon Magazine News

Horizon - The EU research & Innovation Magazine - brings you the latest news and features about thought-provoking science and innovative research projects funded by the EU. This website has recently published an interview with Prof Heidi Larson...

The Steering Committee members of ADVANCE meet Dr Michel Goldman at the ADVANCE Bootcamp to shape the post-project phase

ADVANCE organised a Bootcamp in Leuven (Belgium) on January 24th-26th to discuss the sustainability of the project. During three days the ADVANCE Steering Committee exchanged views and outlined a hub/platform model for the sustainability phase. The...

THE ADVANCE 10TH GAM is approaching

The ADVANCE 10th General Assembly meeting will take place on September 6th and 7th at EMA, London. 

The 9th ADVANCE Forum/General Assembly Meeting

We are pleased to announce that the 9th ADVANCE Forum/General Assembly Meeting will be held on the 10th and 11th of October 2017 in Barcelona. 

D5.6 Results of POC-phase 1 studies

The results described in this report are from the proof of concept studies conducted as part of the IMI ADVANCE project with the aim of testing the methodological aspects of the design, conduct and reporting of studies for vaccine benefit-risk...